JAM3 and systemic sclerosis: In SSc, a disease in which an early proinflammatory state and microvasculopathy progressively culminate in fibrosis and loss of angiogenesis [53,54,55], aberrant JAM-A and JAM-C protein expression was reported in skin biopsies as well as in dermal fibroblasts and ECs [7,27,28].